Physician

Pediatric Infectious Disease

Doctor Ann J. Melvin, MD is an expert in the field of Pediatric Infectious Disease. He went to Tulane University School of Medicine. He over the years received 1 awards: "Regional Top Doctor". Melvin is a published MD as well. He has 39 publications published. The latest was: Pediatric HIV-1 infection.

Publications

---

• Research Recruitment of Adult Survivors of Neonatal Infections: Is There a Role for Parental Consent?
• Plasma and Cerebrospinal Fluid Herpes Simplex Virus Levels at Diagnosis and Outcome of Neonatal Infection.
• Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
• HIV/HBV coinfection in children and antiviral therapy.
• Role for CTSAs in Leveraging a Distributed Research Infrastructure to Engage Diverse Stakeholders in Emergent Research Policy Development.
• Lipid Changes in Kenyan HIV-1-Infected Infants Initiating Highly Active Antiretroviral Therapy by One Year of Age.
• Effectiveness of antenatal group HIV voluntary counseling and testing services in rural India.
• Density-dependent decay in HIV-1 dynamics.
• Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.
• Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.
• Rapid HIV type 1 testing of women presenting in late pregnancy with unknown HIV status in Lima, Peru.
• Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are t...
• Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.
• Efficacy and toxicity of antiretroviral therapy using 4 or more agents: application of a strategy for antiretroviral management in human immunodeficiency virus-infecte...
• Ontogeny of T lymphocyte function in the neonate.
• Lymphokine regulation and the role of abnormal regulation in immunodeficiency.
• Anti-retroviral therapy for HIV-infected children--toward maximal effectiveness.
• Pediatric HIV disease: new developments in treatment and prevention.
• Issues regarding antiretroviral treatment for patients with HIV-1 infection.
• Pediatric human immunodeficiency virus type 1 infection: updates on prevention and management.
• Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.
• Pediatric HIV-1 infection.
• Prevention of mother-to-infant transmission of HIV-1.
• HIV-1 dynamics in children.
• ICD p24 antigen in HIV-infected children with low HIV-specific antibody.
• Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field.
• Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficienc...
• Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors.
• Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women.
• Lack of detection of human immunodeficiency virus type 1 in the saliva of infected children and adolescents.
• Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors.
• Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group.
• Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084.
• Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
• Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C study.
• First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-inf...
• Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses.
• Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.

Schools

---

• Tulane University of Louisiana

• Chldns Hospital Med Center

Doctors Specialties

---

• Pediatric Infectious Disease Medicine
• Pediatric Infectious Disease

Accepted Insurances

---

• Choice Plus POS II
• Blue Card PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• First Choice Health PPO
• First Health (Coventry Health Care) PPO
• Coop Core
• Connect
• Medicare MCR
• Molina
• MultiPlan PPO
• PHCS Network PPO
• ODS Health Plan
• Heritage Plus
• Heritage Signature
• Personal Option EPO
• Preferred Provider Network PPN
• United Healthcare

Awards

---

• Regional Top Doctor

Education

---

• UCSF
• Tulane University School of Medicine

Hospital

---

• Seattle Children's Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Jane L. Burns, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig E. Rubens, MD
	Dr. Janet Englund, MD
	Dr. Penny M. Heaton, MD This Doctor is OpenDoctor Recommended.
	Dr. Heather B. Jaspan, MD This Doctor is OpenDoctor Recommended.
	Dr. Matthew P. Kronman, MD This Doctor is OpenDoctor Recommended.
	Dr. Danielle M. Zerr, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Farah L. Cassis-Ghvami, MD This Doctor is OpenDoctor Recommended.
	Dr. Horacio A. Duarte, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog